Detalhe da pesquisa
1.
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.
Lancet Oncol
; 24(3): 252-261, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858722
2.
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.
Lancet Oncol
; 23(1): 125-137, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34895479
3.
Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study.
Pediatr Blood Cancer
; 66(9): e27873, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31207026
4.
Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groups.
Br J Haematol
; 177(1): 106-115, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28220934
5.
Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE).
Br J Haematol
; 158(5): 649-56, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22757721
6.
Vinblastine in the treatment of children and adolescents with refractory immune thrombocytopenia.
Am J Hematol
; 86(9): 785-7, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21800354
7.
Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - an Anglo-French collaborative report.
Eur J Cancer
; 48(11): 1700-6, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22093944